Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals

Psychopharmacology

Volumn 231, Issue 18, 2014, Pages 3799-3807

  Schacht, Joseph P ^a   Anton, Raymond F ^a   Randall, Patrick K ^a   Li, Xingbao ^a   Henderson, Scott ^a   Myrick, Hugh ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Alcohol; Craving; fMRI; Neuroimaging; Varenicline

Indexed keywords

PLACEBO; VARENICLINE; BENZAZEPINE DERIVATIVE; NICOTINIC AGENT; QUINOXALINE DERIVATIVE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORPUS STRIATUM; DRINKING BEHAVIOR; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEADACHE; HUMAN; IMAGE ANALYSIS; MALE; MEDICATION COMPLIANCE; NEUROIMAGING; ORBITAL CORTEX; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PILOT STUDY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REWARD; SMOKING; WITHDRAWAL SYNDROME; ASSOCIATION; BRAIN; BRAIN MAPPING; CRAVING; DRUG EFFECTS; MIDDLE AGED; MOTIVATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; BENZAZEPINES; BRAIN; BRAIN MAPPING; CRAVING; CUES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTIVATION; NICOTINIC AGONISTS; PILOT PROJECTS; QUINOXALINES; REWARD; VARENICLINE; YOUNG ADULT;

EID: 84906934800     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3518-1     Document Type: Article

References (46)

1. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (4th edn., text rev.). Author, Washington
2. Anton RF, Moak DH, Latham PK (1996) The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 53:225-231 (Pubitemid 26085204)
3. Childs E, Roche DJ, King AC, de Wit H (2012) Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements. Alcohol Clin Exp Res 36:906-914
4. Claus ED, Ewing SW, Filbey FM, Sabbineni A, Hutchison KE (2011) Identifying neurobiological phenotypes associated with alcohol use disorder severity. Neuropsychopharmacology 36:2086-2096
5. Di Chiara G (2000) Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393:295-314
6. Ericson M, Blomqvist O, Engel JA, Soderpalm B (1998) Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine. Eur J Pharmacol 358:189-196 (Pubitemid 28498177)
7. Filbey FM, Claus E, Audette AR, Niculescu M, Banich MT, Tanabe J et al (2008) Exposure to the taste of alcohol elicits activation of the mesocorticolimbic neurocircuitry. Neuropsychopharmacology 33:1391-1401 (Pubitemid 351521721)
8. First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured clinical interview for DSM-IV-TR axis I disorders, research version, non-patient edition. Biometrics Research, New York State Psychiatric Institute, New York
9. Franklin T, Wang Z, Suh JJ, Hazan R, Cruz J, Li Yet al (2011) Effects of varenicline on smoking cue-triggered neural and craving responses. Arch Gen Psychiatry 68:516-526
10. Fucito LM, Toll BA, Wu R, Romano DM, Tek E, O'Malley SS (2011) A preliminary investigation of varenicline for heavy drinking smokers. Psychopharmacology (Berl) 215:655-663
11. Hermann D, Smolka MN, Wrase J, Klein S, Nikitopoulos J, Georgi A, Braus DF, Flor H, Mann K, Heinz A (2006) Blockade of cue-induced brain activation of abstinent alcoholics by a single administration of amisulpride as measured with fMRI. Alcohol Clin Exp Res 30:1349-1354 (Pubitemid 44114685)
12. Kamens HM, Andersen J, Picciotto MR (2010a) The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice. Alcohol Clin Exp Res 34:2053-2060
13. Kamens HM, Andersen J, Picciotto MR (2010b) Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice. Psychopharmacology (Berl) 208:613-626
14. Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217-238
15. Kringelbach ML, Rolls ET (2004) The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog Neurobiol 72:341-372 (Pubitemid 38626161)
16. Levine J, Schooler NR (1986) SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 22:343-381 (Pubitemid 16043808)
17. Litten RZ, Ryan ML, Fertig JB, Falk DE, Johnson B, Dunn KE et al (2013) A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. J Addict Med 7(4):277-286
18. Lotfipour S, Mandelkern M, Alvarez-Estrada M, Brody AL (2012) A single administration of low-dose varenicline saturates alpha4beta2*nicotinic acetylcholine receptors in the human brain. Neuropsychopharmacology 37:1738-1748
19. Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S et al (2010) Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry 67:715-721
20. Lukas SE, Lowen SB, Lindsey KP, Conn N, Tartarini W, Rodolico J et al (2013) Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study. NeuroImage 78:176-185
21. McKee SA, Harrison EL, O'Malley SS, Krishnan-Sarin S, Shi J, Tetrault JM et al (2009) Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry 66:185-190
22. Mitchell JM, Teague CH, Kayser AS, Bartlett SE, Fields HL (2012) Varenicline decreases alcohol consumption in heavy-drinking smokers. Psychopharmacology (Berl) 223:299-306
23. Mocking RJ, Patrick Pflanz C, Pringle A, Parsons E, McTavish SF, Cowen PJ et al (2013) Effects of a short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, study. Neuropsychopharmacology 38:476-484
24. Myrick H, Anton RF, Li X, Henderson S, Drobes D, Voronin K et al (2004) Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology 29:393-402 (Pubitemid 38175156)
25. Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K (2008) Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry 65:466-475 (Pubitemid 351519896)
26. Myrick H, Li X, Randall PK, Henderson S, Voronin K, Anton RF (2010) The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. J Clin Psychopharmacol 30:365-372
27. Plebani JG, Lynch KG, Rennert L, Pettinati HM, O'Brien CP, Kampman KM (2013) Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence. Drug Alcohol Depend 133(2):754-758
28. Ray LA, Lunny K, Bujarski S, Moallem N, Krull JL, Miotto K (2013) The effects of varenicline on stress-induced and cue-induced craving for cigarettes. Drug Alcohol Depend 131:136-142
29. Roberts JS, Anton RF, Latham PK, Moak DH (1999) Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale. Alcohol Clin Exp Res 23:1484-1491 (Pubitemid 29468445)
30. Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA et al (2007) Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985-994 (Pubitemid 46227486)
31. Sayette MA, Shiffman S, Tiffany ST, Niaura RS, Martin CS, Shadel WG (2000) The measurement of drug craving. Addiction 95(Suppl 2):S189-S210 (Pubitemid 30650382)
32. Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H (2011) Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach. NeuroImage 56:61-68
33. Schacht JP, Anton RF, Myrick H (2013a) Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol 18:121-133
34. Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H (2013b) Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics. Psychopharmacology (Berl) 227(4):627-637
35. Schacht JP, Anton RF, Voronin KE, Randall PK, Li X, Henderson S et al (2013c) Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacology 38:414-422
36. Skinner HA, Allen BA (1982) Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 91:199-209
37. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H et al (2004) Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23(Suppl 1):S208-S219 (Pubitemid 39421720)
38. Sobell LC, Sobell MB (1992) Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Allen JP, Litten RZ (eds) Measuring alcohol consumption: psychosocial and biochemical methods. Humana Press, Totowa, pp 41-72
39. Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE (2007) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci U S A 104:12518-12523 (Pubitemid 47206170)
40. Stritzke WG, Breiner MJ, Curtin JJ, Lang AR (2004) Assessment of substance cue reactivity: advances in reliability, specificity, and validity. Psychol Addict Behav 18:148-159 (Pubitemid 38808565)
41. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84:1353-1357 (Pubitemid 19281139)
42. Tizabi Y, Copeland RL Jr, Louis VA, Taylor RE (2002) Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens. Alcohol Clin Exp Res 26:394-399 (Pubitemid 34225846)
43. Volkow ND, Wang G-J, Telang F, Fowler JS, Logan J, Jayne M et al (2007) Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci 27:12700-12706 (Pubitemid 350127825)
44. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F (2011) Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci U S A 108:15037-15042
45. Wiers RW, Eberl C, Rinck M, Becker ES, Lindenmeyer J (2011) Retraining automatic action tendencies changes alcoholic patients' approach bias for alcohol and improves treatment outcome. Psychol Sci 22:490-497
46. Wouda JA, Riga D, De Vries W, Stegeman M, van Mourik Y, Schetters D et al (2011) Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control. Psychopharmacology (Berl) 216:267-277